| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy: results and perspectives
|
Evans, W.K.
|
|
1995
|
12 |
S1 |
p. S35-S45
11 p.
|
artikel
|
| 2 |
A phase ii trial of combined chemotherapy and surgery in stage iiia non-small cell lung cancer
|
Darwish, Samir
|
|
1995
|
12 |
S1 |
p. S71-S78
8 p.
|
artikel
|
| 3 |
Biological prognostic factors in non-small cell lung cancer
|
Sotti, Giorgio Vittorio
|
|
1995
|
12 |
S1 |
p. S13-S25
13 p.
|
artikel
|
| 4 |
Biological response modifiers
|
Calabresi, F.
|
|
1995
|
12 |
S1 |
p. S193-S198
6 p.
|
artikel
|
| 5 |
Camptothecin analogues in the treatment of non-small cell lung cancer
|
Ardizzoni, A.
|
|
1995
|
12 |
S1 |
p. S177-S185
9 p.
|
artikel
|
| 6 |
Edatrexate studies in non-small cell lung cancer
|
Gralla, Richard J.
|
|
1995
|
12 |
S1 |
p. S187-S191
5 p.
|
artikel
|
| 7 |
Effectiveness and toxicity of preoperative therapy in stage iiia non-small cell lung cancer including the memorial sloan-kettering experience with induction mvp in patients with bulky mediastinal lymph node metastases (Clinical n2)
|
Kris, Mark G.
|
|
1995
|
12 |
S1 |
p. S47-S57
11 p.
|
artikel
|
| 8 |
Epidemiology of lung cancer: Recent trends in mortality with emphasis on Europe
|
Negri, Eva
|
|
1995
|
12 |
S1 |
p. S3-S11
9 p.
|
artikel
|
| 9 |
Future directions and strategies
|
McVie, J. Gordon
|
|
1995
|
12 |
S1 |
p. S199-S201
3 p.
|
artikel
|
| 10 |
Gemcitabine in non-small cell lung cancer
|
Sørensen, J.B.
|
|
1995
|
12 |
S1 |
p. S173-S175
3 p.
|
artikel
|
| 11 |
Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience
|
Cesne, A. Le
|
|
1995
|
12 |
S1 |
p. S79-S85
7 p.
|
artikel
|
| 12 |
Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer
|
Souquet, P.-J.
|
|
1995
|
12 |
S1 |
p. S147-S154
8 p.
|
artikel
|
| 13 |
Multimodality therapy in unresected stage iii non-small cell lung cancer: the american cooperative groups' experience
|
Green, Mark R.
|
|
1995
|
12 |
S1 |
p. S87-S94
8 p.
|
artikel
|
| 14 |
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in Stage IIIA non-small cell lung cancer
|
Rosell, Rafael
|
|
1995
|
12 |
S1 |
p. S59-S70
12 p.
|
artikel
|
| 15 |
Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer
|
Pujol, Jean-Louis
|
|
1995
|
12 |
S1 |
p. S107-S118
12 p.
|
artikel
|
| 16 |
New drugs in non-small cell lung cancer. An overview
|
Giaccone, Giuseppe
|
|
1995
|
12 |
S1 |
p. S155-S162
8 p.
|
artikel
|
| 17 |
Paclitaxel (Taxol) and Docetaxel (Taxotere): active chemotherapeutic agents in lung cancer
|
Francis, Prudence A.
|
|
1995
|
12 |
S1 |
p. S163-S172
10 p.
|
artikel
|
| 18 |
Prognostic factors in NSCLC. Recent experiences
|
Zandwijk, Nico van
|
|
1995
|
12 |
S1 |
p. S27-S33
7 p.
|
artikel
|
| 19 |
Radiotherapy in non-small cell lung cancer: optimal doses and schedules
|
Schaake-Koning, C.
|
|
1995
|
12 |
S1 |
p. S119-S123
5 p.
|
artikel
|
| 20 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the italian oncology group for clinical research
|
Crinòc*, Lucio
|
|
1995
|
12 |
S1 |
p. S125-S132
8 p.
|
artikel
|
| 21 |
The Perugia International Cancer Conference IV
|
Tonato, Maurizio
|
|
1995
|
12 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 22 |
Therapy of non-small cell lung cancer
|
Klastersky, J.
|
|
1995
|
12 |
S1 |
p. S133-S145
13 p.
|
artikel
|
| 23 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer
|
Cullen, Michael H.
|
|
1995
|
12 |
S1 |
p. S95-S106
12 p.
|
artikel
|
Tijdschrift beschrijving